• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-26

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, capturing tumor microenvironment complexity. The approach enhances preclinical drug testing, revealing stromal influence on drug response and resistance mechanisms, with significant implications for personalized therapy development.

• EZ Cap™ Human PTEN mRNA: Mechanistic Insights for Cancer Res

  2026-05-26

  EZ Cap™ Human PTEN mRNA is a rigorously engineered tumor suppressor gene mRNA that enables stable, high-fidelity PTEN expression for cancer and gene therapy research. Its Cap 1 and poly(A) tail modifications enhance translation and minimize immune activation, providing a robust platform for studying PI3K/Akt pathway regulation and mRNA delivery strategies. This dossier details the molecular rationale, supporting evidence, and key workflow parameters for effective experimental use.

• Otilonium Bromide: Antimuscarinic Agent for Cholinergic Path

  2026-05-25

  Otilonium Bromide is a high-purity antimuscarinic agent used in research for precise inhibition of acetylcholine receptors. Its robust solubility and validated mechanism enable reproducible studies in neuroscience and smooth muscle pharmacology.

• BML-277 and the Nuclear cGAS–Chk2 Axis: New Frontiers in DNA

  2026-05-25

  This thought-leadership article illuminates the mechanistic interplay between Chk2 and nuclear cGAS in genome stability, drawing on fresh research and strategic workflow guidance. It reveals how BML-277, a potent and selective Chk2 inhibitor from APExBIO, empowers translational researchers to dissect checkpoint signaling, radioprotection of T-cells, and the emerging cGAS–TRIM41–ORF2p pathway. Uniting protocol specifics, competitive analysis, and a forward-looking outlook, this article charts new territory for advancing DNA damage response research and translational innovation.

• Pentoxifylline Suppresses Neonatal Monocyte Hyperinflammatio

  2026-05-24

  Schüller et al. demonstrate that pentoxifylline (PTX) robustly attenuates LPS-induced hyperinflammatory responses in monocytes from preterm infants, with distinct age-dependent effects on marker expression and cytokine production. Their findings highlight PTX’s potential as an adjunct therapy in neonatal sepsis by targeting TLR4 signaling and key inflammatory mediators, informing both mechanistic understanding and translational research design.

• (S)-(+)-Ibuprofen: Strategic Paths for Translational Inflamm

  2026-05-23

  This thought-leadership article explores (S)-(+)-Ibuprofen as a model COX inhibitor, blending mechanistic insight with actionable strategic guidance for translational researchers. Anchored in recent advances in ibuprofen synthesis and experimental workflows, it highlights how precision use of this pharmacologically active enantiomer by APExBIO can drive reproducible inflammation and pain pathway studies. The article contrasts evolving synthetic routes, contextualizes (S)-(+)-Ibuprofen within the nonsteroidal anti-inflammatory drug landscape, and outlines forward-looking considerations for maximizing its translational impact.

• Forskolin as an Adenylate Cyclase Activator in Stem Cell Ass

  2026-05-22

  Forskolin's precision as an adenylate cyclase activator enables reproducible cAMP-driven modulation in stem cell, neuroendocrine, and disease model assays. Explore robust protocols, troubleshooting insights, and the translational advances Forskolin unlocks—especially its impact on human mesenchymal stem cell workflows and regenerative applications.

• Paclitaxel (Taxol): Redefining Microtubule Modulation in Can

  2026-05-22

  This thought-leadership article integrates cutting-edge mechanistic insights with strategic guidance for translational cancer researchers, spotlighting Paclitaxel (Taxol) as both an established and evolving microtubule polymer stabilizer. We examine recent discoveries in α-tubulin posttranslational modifications, practical workflow parameters, and the critical translational bridge from in vitro modeling to clinical relevance, while differentiating APExBIO Paclitaxel as a key research enabler.

• EV-Transferred ACLY Drives Macrophage Differentiation in HCC

  2026-05-21

  This study uncovers a mechanism by which hepatocellular carcinoma (HCC) cells secrete extracellular vesicles loaded with ATP-citrate lyase (ACLY), driving monocyte differentiation into immunosuppressive tumor-associated macrophages (TAMs). These findings highlight new opportunities for targeted immunometabolic interventions in HCC, particularly through the disruption of EV-mediated ACLY transfer.

• RNAPII Degradation Drives Chromatin Reorganization in Oocyte

  2026-05-21

  The referenced study uncovers that degradation of RNA polymerase II (RNAPII), rather than simple transcriptional inhibition, is the central mechanism driving the crucial chromatin transition (NSN-to-SN) during mammalian oocyte maturation. This finding revises our understanding of oogenesis and establishes new mechanistic links between transcriptional regulation and developmental competence in preimplantation embryos.

• (S)-(+)-Ibuprofen (SKU B1018): Reliable COX Inhibition in Ce

  2026-05-20

  (S)-(+)-Ibuprofen (SKU B1018) delivers reproducible, selective COX inhibition for cell viability, proliferation, and cytotoxicity assays. This scenario-driven guide addresses experimental pain points, protocol optimization, and product selection—empowering biomedical researchers to achieve robust, data-backed outcomes with confidence.

• TANGO2 Identified as an Acyl-CoA Binding Protein in Mitochon

  2026-05-20

  The reference study establishes TANGO2 as a mitochondrial acyl-CoA binding protein, localizing it within the mitochondrial lumen and linking its dysfunction to metabolic crises in humans. This work clarifies TANGO2's mechanistic role in lipid metabolism, with implications for understanding and modeling metabolic disorders.

• PreScission Protease: Precision HRV 3C Protease for Tag Clea

  2026-05-19

  PreScission Protease (PSP) from APExBIO excels in low-temperature, high-specificity fusion tag removal, uniquely supporting workflows sensitive to protein conformation and activity. Its Gln-Gly site specificity and robust GST fusion protein compatibility empower advanced studies in condensate biology and chromatin research.

• Dual Mitophagy Activation via H2S Axis in Cerebral Ischemia

  2026-05-19

  This study reveals how enriched environmental exposure mitigates cerebral ischemia–reperfusion injury by activating dual mitophagy pathways through a dopamine–H2S signaling axis. By uncovering mitochondrial quality control mechanisms involving both PINK1/parkin and HIF-1α/BNIP3L, the research offers new directions for neuroprotection against stroke-induced oxidative stress.

• EZ Cap™ Human PTEN mRNA: Cap 1-Modified Tumor Suppressor Too

  2026-05-18

  EZ Cap™ Human PTEN mRNA is a Cap 1-modified, poly(A)-tailed mRNA encoding the human PTEN tumor suppressor gene, optimized for high stability and translatability in cancer research and gene therapy. This product enables precise restoration of PTEN function and modulation of PI3K/Akt signaling, filling critical gaps in tumor suppressor gene mRNA delivery strategies.

16228 records 1/1082 page Next 12345 下5页 Last page